PNPLA2 and metabolic dysfunction-associated steatohepatitis: Indeed, the overexpression of diacylglycerol acyltransferase 2 (DGAT2) in mice or the deletion of adipose triglyceride lipase (ATGL) in hepatocytes increase steatosis without promoting inflammation, a key feature of NASH (7, 8).